ALK and inflammatory myofibroblastic tumor: ALK fusion genes drive tumorigenesis across a variety of different malignancies including anaplastic large cell lymphoma (ALCL) [5], non-small-cell lung cancer (NSCLC) [6] and inflammatory myofibroblastic tumor (IMT) [7].